Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
2.150
+0.110 (5.39%)
Nov 20, 2024, 4:00 PM EST - Market closed

Envoy Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21
Revenue
0.280.320.240.31
Revenue Growth (YoY)
15.35%33.33%-23.55%-
Cost of Revenue
0.820.790.50.77
Gross Profit
-0.54-0.47-0.26-0.46
Selling, General & Admin
10.168.943.472.47
Research & Development
10.768.964.983.94
Operating Expenses
20.9317.98.456.41
Operating Income
-21.47-18.37-8.71-6.87
Other Non Operating Income (Expenses)
0.841.8-0.13-1.8
EBT Excluding Unusual Items
-21.06-16.58-8.83-8.67
Gain (Loss) on Sale of Assets
----0
Other Unusual Items
--13.33-7.09-
Pretax Income
-21.06-29.91-15.92-8.68
Net Income
-21.06-29.91-15.92-8.68
Net Income to Common
-25.17-29.91-15.92-8.68
Shares Outstanding (Basic)
20131010
Shares Outstanding (Diluted)
20131010
Shares Change (YoY)
93.59%24.00%-0.04%-
EPS (Basic)
-1.28-2.38-1.57-0.86
EPS (Diluted)
-1.28-2.38-1.57-0.86
Free Cash Flow
-26.8-17.81-9.02-7.06
Free Cash Flow Per Share
-1.36-1.42-0.89-0.70
Gross Margin
-194.60%-149.68%-110.13%-148.06%
Operating Margin
-7721.94%-5813.61%-3673.42%-2216.45%
Profit Margin
-9053.24%-9464.56%-6718.57%-2798.39%
Free Cash Flow Margin
-9641.73%-5635.13%-3807.17%-2277.74%
EBITDA
-21.29-18.24-8.63-6.8
D&A For EBITDA
0.170.130.080.07
EBIT
-21.47-18.37-8.71-6.87
Source: S&P Capital IQ. Standard template. Financial Sources.